Experience the "Xiamen Day" at Expo 2025 Osaka and Embark on a New Journey of Diverse Exchange
HTX Launches Multi-Assets Collateral Mode for USDT-Margined Futures, Empowering Traders With Enhanced Capital Efficiency
Minghui Pharmaceutical Announces First Patient Dosed in the Phase Ⅱ Combination Study of PD-1xVEGF Bispecific and TROP-2 ADC in Advanced NSCLC
MiTAC Computing Democratizes AI at COMPUTEX 2025
Storage Meets AI at COMPUTEX 2025: Lexar Introduces Innovative Product Lines
Ascletis Announces First Participants Dosed in a U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity
BioFlag Showcases Innovative Probiotic Solutions at Vitafoods Europe 2025
ZKH Group Limited Announces First Quarter 2025 Unaudited Financial Results



